Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute lymphocytic leukemia-associated cell membrane antigen.

R Billing, J Minowada, M Cline

    Journal of the National Cancer Institute
    |August 1, 1978
    PubMed
    Summary

    Researchers developed a new antiserum to identify non-B, non-T acute lymphocytic leukemia (ALL) cells. This antiserum shows promise in diagnosing various leukemias, including a specific type of chronic myelocytic leukemia (CML).

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Arboviruses in UK Armed Forces: a review of historical cases and identification of future threats.

    BMJ military health·2025
    Same author

    Is an Online Asynchronous Progressive Resistance Training Programme Feasible for Individuals With Down Syndrome?

    Journal of applied research in intellectual disabilities : JARID·2025
    Same author

    Animal health and welfare as a public good: what do the public think?

    Agriculture and human values·2024
    Same author

    State Leadership Academies to reduce cigarette smoking among people with behavioral health conditions in the United States.

    Preventive medicine reports·2024
    Same author

    Cross-disciplinary heat acclimatization research for climate change resilience.

    Journal of applied physiology (Bethesda, Md. : 1985)·2024
    Same author

    Interspecies encounters with endemic health conditions: co-producing BVD and lameness with cows and sheep in the north of England.

    Sociologia ruralis·2024

    Area of Science:

    • Immunology
    • Hematology
    • Oncology

    Background:

    • Non-B, non-T acute lymphocytic leukemia (ALL) requires specific diagnostic markers.
    • Existing antisera may lack specificity for certain leukemia subtypes.

    Purpose of the Study:

    • To develop and characterize a novel antiserum targeting non-B, non-T ALL cells.
    • To evaluate the diagnostic potential of this antiserum across various leukemia types.

    Main Methods:

    • Raising antisera in rabbits against non-B, non-T ALL cells.
    • Absorption assays with chronic lymphocytic leukemia (CLL) cells.
    • Cytotoxicity and immunofluorescence testing on leukemia cell lines and patient samples.
    • Immunoprecipitation and polyacrylamide gel electrophoresis to determine antigen characteristics.

    Related Experiment Videos

    Main Results:

    • The developed antiserum specifically reacted with non-B, non-T ALL cells.
    • Positive reactions were observed in 13/18 ALL patients, 1/8 chronic myelocytic leukemia (CML) patients in blast crisis, and none with acute myelocytic leukemia or CLL.
    • The ALL antigen was identified as a single polypeptide chain of approximately 98,000 daltons.
    • The antiserum did not show cytotoxicity against normal myeloid stem cells.

    Conclusions:

    • The novel antiserum is a potential diagnostic tool for non-B, non-T ALL.
    • The antiserum's reactivity profile suggests utility in differentiating leukemia subtypes.
    • The identified ALL antigen provides a target for further immunotherapeutic strategies.